ALAVERT ALLERGY

Manufacturer
Haleon US Holdings LLC
Effective date
2024-03-21
Label type
HUMAN OTC DRUG LABEL
Version
13
Source
legacy-cache
Hydrated at
2026-08-01 21:07:37

Label at a glance#

ProductALAVERT ALLERGY
Active ingredientLORATADINE
Label structure10 sections

Indications and uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

Dosage and administration

tablet melts in mouth. Can be taken with or without water. Age Dose adults and children 6 years and over 1 tablet daily; do not use more than 1 tablet daily children under 6 ask a doctor consumers who have liver or kidney disease ask a doctor

Label contents#

Full prescribing information#

ACTIVE INGREDIENT (IN EACH TABLET)

OTC - ACTIVE INGREDIENT SECTION

Loratadine 10 mg

PURPOSE

OTC - PURPOSE SECTION

Antihistamine

USES

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

WARNINGS

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

if you have ever had an allergic reaction to this product or any of its ingredients

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product

OTC - WHEN USING SECTION

do not use more than directed. Taking more than recommended may cause drowsiness.

Stop use and ask a doctor if

OTC - STOP USE SECTION

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

  • tablet melts in mouth. Can be taken with or without water.
AgeDose

adults and children 6 years and over

1 tablet daily; do not use more than 1 tablet daily

children under 6

ask a doctor

consumers who have liver or kidney disease

ask a doctor

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

  • Phenylketonurics:Contains Phenylalanine 8.4 mg per tablet
  • store at 20-25ºC (68-77ºF)
  • keep in a dry place

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Alavert Allergy Fresh Mint

INACTIVE INGREDIENT SECTION

anhydrous citric acid, aspartame, colloidal silicon dioxide, corn syrup solids, crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, modified starch, natural and artificial flavors, sodium bicarbonate

Alavert Allergy Citrus Burst

INACTIVE INGREDIENT SECTION

anhydrous citric acid, aspartame, butylated hydroxyanisole, colloidal silicon dioxide, corn syrup solids, crospovidone, dextrin, ferric oxides, magnesium stearate, maltodextrin, mannitol, microcrystalline cellulose, modified starch, natural and artificial flavors, sodium bicarbonate

QUESTIONS OR COMMENTS?

OTC - QUESTIONS SECTION

call weekdays from 9 AM to 5 PM EST at 1-800-ALAVERT (1-800-252-8378)

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

The product packaging shown below represents a sample of that currently in use. Additional packaging may also be available.

ALAVERT allergy Fresh Mint

Loratadine Orally Disintegrating Tablet, 10 mg, Antihistamine

18 Orally Disintegrating Tablets

TASTES GREAT!

Melts in your Mouth!

Non-Drowsy* Allergy Relief

*When taken as directed. See Drug Facts Panel.

24 HOUR Relief of

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itching of Nose & Throat

Compare to Claritin †& SAVE!

†Claritin is a registered trademark of Schering Corporation

Alavert Allergy Fresh Mint Packaging
Alavert Allergy Fresh Mint Packaging

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ALAVERT allergy Citrus Burst

Loratadine Orally Disintegrating Tablet, 10 mg, Antihistamine

18 Orally Disintegrating Tablets

TASTES GREAT!

Melts in your Mouth!

Non-Drowsy* Allergy Relief

*When taken as directed. See Drug Facts Panel.

24 HOUR Relief of

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itching of Nose & Throat

Compare to Claritin† & SAVE!

†Claritin is a registered trademark of Schering Corporation

Alavert Allergy Citrus Burst Packaging
Alavert Allergy Citrus Burst Packaging

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0573-2620-06EA - Each0573-2620a426c267-75e5-4ee7-9ccb-d16f65916fb812013-02-11
0573-2620-19EA - Each0573-2620803dfd04-b25f-4194-9168-06ac1786360912012-07-24
0573-2620-30EA - Each0573-26207da8de28-0e7a-453a-81e4-006ec98783a212014-01-04
0573-2620-65EA - Each0573-2620526cf195-dcb5-4dc1-ab35-715787f1e3d712012-07-24
0573-2621-19EA - Each0573-26211fcf8024-13e4-4f89-8a06-70c42d58133812014-01-04
0573-2621-65EA - Each0573-262188b60682-6817-47c6-87b5-205696e5dc0312012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
LORATADINEACTIVE INGREDIENT7AJO3BO7QN7
LORATADINEACTIVE MOIETY7AJO3BO7QN7
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSL7
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR17
BUTYLATED HYDROXYANISOLEINACTIVE INGREDIENTREK4960K2U7
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U7
CORN SYRUPINACTIVE INGREDIENT9G5L16BK6N7
CROSPOVIDONEINACTIVE INGREDIENT68401960MK7
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6757
ICODEXTRININACTIVE INGREDIENT2NX48Z0A9G7
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I307
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2D7
MANNITOLINACTIVE INGREDIENT3OWL53L36A7
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU47
SODIUM BICARBONATEINACTIVE INGREDIENT8MDF5V39QO7

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 372 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ICODEXTRINICODEXTRIN2NX48Z0A9GSHAMPOO / TOPICAL5 %w/wExact identifier — unii candidate
7 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / TOPICAL6 mgExact identifier — unii candidate
49 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, COATED / ORAL177.7 mgExact identifier — unii candidate
65 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL78 mgExact identifier — unii candidate
19 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE, EXTENDED RELEASE / ORAL1246 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER, FOR SUSPENSION / ORAL120 mgExact identifier — unii candidate
39 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CREAM / TOPICALNAExact identifier — unii candidate
21 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLAEROSOL, FOAM / TOPICAL6 mgExact identifier — unii candidate
61 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE, COATED PELLETS / ORAL456 mgExact identifier — unii candidate
28 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ACAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
65 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE / ORAL2169 mgExact identifier — unii candidate
28 equally ranked IID candidates
CORN SYRUPCORN SYRUP9G5L16BK6NSOLUTION / ORAL750 mg/5mlExact identifier — unii candidate
10 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, ORALLY DISINTEGRATING / ORAL1800 mgExact identifier — unii candidate
28 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4FILM, SOLUBLE / ORAL2 mgExact identifier — unii candidate
49 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET / BUCCAL360 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION / SUBCUTANEOUS675 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, ORALLY DISINTEGRATING / ORAL187 mgExact identifier — unii candidate
39 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOGUM, CHEWING / BUCCAL240 mgExact identifier — unii candidate
34 equally ranked IID candidates
CORN SYRUPCORN SYRUP9G5L16BK6NSUSPENSION, EXTENDED RELEASE / ORAL1500 mg/5mlExact identifier — unii candidate
10 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLFILM, SOLUBLE / ORAL7 mgExact identifier — unii candidate
61 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, EXTENDED RELEASE / ORAL7 mgExact identifier — unii candidate
21 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675LOTION / TOPICALNAExact identifier — unii candidate
21 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1CAPSULE, EXTENDED RELEASE / ORAL3 mgExact identifier — unii candidate
19 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DPOWDER, FOR SUSPENSION / ORAL8000 mgExact identifier — unii candidate
15 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1TABLET, CHEWABLE / ORAL195 mgExact identifier — unii candidate
19 equally ranked IID candidates
ICODEXTRINICODEXTRIN2NX48Z0A9GLOTION / TOPICALNAExact identifier — unii candidate
7 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UCAPSULE, LIQUID FILLED / ORAL4 mgExact identifier — unii candidate
24 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / BUCCAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30RING / VAGINAL2 mgExact identifier — unii candidate
39 equally ranked IID candidates
ICODEXTRINICODEXTRIN2NX48Z0A9GTABLET, EXTENDED RELEASE / ORAL6 mgExact identifier — unii candidate
7 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, DELAYED RELEASE / ORAL3.2 mgExact identifier — unii candidate
49 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSPRAY / TOPICAL0.01 %w/wExact identifier — unii candidate
61 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1TABLET / SUBLINGUAL8 mgExact identifier — unii candidate
19 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30INSERT / VAGINAL69 mgExact identifier — unii candidate
39 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR1000 mgExact identifier — unii candidate
34 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS658 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CREAM / TOPICALNAExact identifier — unii candidate
39 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / TOPICAL4.35 %w/vExact identifier — unii candidate
61 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UOINTMENT / VAGINAL0.02 %w/wExact identifier — unii candidate
24 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLINJECTION, SOLUTION / INTRAMUSCULAR25 mgExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSUSPENSION/ DROPS / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLTABLET / SUBLINGUAL36 mgExact identifier — unii candidate
61 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1TABLET, FOR SUSPENSION / ORAL15 mgExact identifier — unii candidate
19 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTROCHE / ORAL300 mgExact identifier — unii candidate
28 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / ORAL3900 mgExact identifier — unii candidate
61 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2ULOTION / TOPICALNAExact identifier — unii candidate
24 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE, COATED / ORAL0.12 mgExact identifier — unii candidate
21 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / RESPIRATORY (INHALATION)0.13 mgExact identifier — unii candidate
39 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE / ORAL5 mgExact identifier — unii candidate
21 equally ranked IID candidates
CORN SYRUPCORN SYRUP9G5L16BK6NTABLET / ORAL14.07 mgExact identifier — unii candidate
10 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UCREAM / TOPICAL2 mgExact identifier — unii candidate
24 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SOLUTION / ORAL336 mgExact identifier — unii candidate
49 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, CHEWABLE / ORAL1725 mgExact identifier — unii candidate
28 equally ranked IID candidates
BUTYLATED HYDROXYANISOLEBUTYLATED HYDROXYANISOLEREK4960K2UCAPSULE / ORAL4 mgExact identifier — unii candidate
24 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS35 mgExact identifier — unii candidate
61 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC4.35 %w/wExact identifier — unii candidate
65 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DFILM, SOLUBLE / ORAL19 mgExact identifier — unii candidate
15 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASPRAY / NASAL41.5 mgExact identifier — unii candidate
65 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOINSERT / VAGINAL129 mgExact identifier — unii candidate
34 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021375-001ALAVERTLORATADINE10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1984e616aacf4f…
2026-08-18 06:07:402026-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-194b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1974a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1987673890dc5c…
2021-03-12 10:30 UTC2021-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f01610625f2…
2019-09-15 20:21 UTC2019-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b00525d2431f…
2019-07-19 19:46 UTC2019-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-199b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f0d92c62455…
2023-05-13 08:27 UTC2023-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19053a50430f4f…
2023-01-26 05:58 UTC2023-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
181d3342-4e2f-7aad-e063-6294a90a8d9cf45af3e4-5dd5-ea0a-c47c-8d68a12491582024-05-10WarningsExact identifier
spl set id: f45af3e4-5dd5-ea0a-c47c-8d68a1249158

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.